Peter Fedichev is a scientist and entrepreneur with over 20 years of experience in academic research and the biotech industry. He is the CEO of Gero.ai, a biotechnology company using AI to understand and combat aging and chronic diseases. Gero.ai has developed proprietary physics-based machine learning models, called Large Health Models (LHMs), to analyze health data, distinguish aging from disease effects, and improve drug discovery and development.

Peter holds an M.S. in theoretical physics from the Moscow Institute of Physics and Technology and a Ph.D. from the University of Amsterdam. He has conducted research at institutions including the Kurchatov Institute, University of Amsterdam, FOM Institute AMOLF, and University of Innsbruck. With over 80 publications and 6,000+ citations (h-index of 37), his work has advanced the understanding of aging and lifespan limits. He is driven by the challenge of aging research and dreams of extending human lifespan and experiencing life in space.